The type 1 diabetes susceptibility locus Idd5 favours robust neonatal development of highly autoreactive regulatory T cells in the NOD mouse

Front Immunol. 2024 Feb 9:15:1358459. doi: 10.3389/fimmu.2024.1358459. eCollection 2024.

Abstract

Regulatory T lymphocytes expressing the transcription factor Foxp3 (Tregs) play an important role in the prevention of autoimmune diseases and other immunopathologies. Aberrations in Treg-mediated immunosuppression are therefore thought to be involved in the development of autoimmune pathologies, but few have been documented. Recent reports indicated a central role for Tregs developing during the neonatal period in the prevention of autoimmune pathology. We therefore investigated the development of Tregs in neonatal NOD mice, an important animal model for autoimmune type 1 diabetes. Surprisingly, we found that, as compared with seven other commonly studied inbred mouse strains, in neonatal NOD mice, exceptionally large proportions of developing Tregs express high levels of GITR and PD-1. The latter phenotype was previously associated with high Treg autoreactivity in C57BL/6 mice, which we here confirm for NOD animals. The proportions of newly developing GITRhighPD-1+ Tregs rapidly drop during the first week of age. A genome-wide genetic screen indicated the involvement of several diabetes susceptibility loci in this trait. Analysis of a congenic mouse strain confirmed that Idd5 contributes to the genetic control of GITRhighPD-1+ Treg development in neonates. Our data thus demonstrate an intriguing and paradoxical correlation between an idiosyncrasy in Treg development in NOD mice and their susceptibility to type 1 diabetes.

Keywords: Idd5; immune tolerance; regulatory T cells; thymus; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 1* / genetics
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Programmed Cell Death 1 Receptor / genetics
  • T-Lymphocytes, Regulatory
  • Transcription Factors

Substances

  • Programmed Cell Death 1 Receptor
  • Transcription Factors

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was financially supported by the Fondation pour la Recherche Médicale (to JvM, DEQ20160334920; to JS, FDT201904008280); the IdEx Toulouse (to PR); the Agence Nationale pour la Recherche (to PR, ANR-16-CE15-0015-01, to JvM ANR-23-CE15-0010-01), and by a “scientific exchanges grant” from the Swiss National Fund (to JvM).